Clone 17/2 recognizes recombinant human Follistatin 288, allowing for detection of FSH levels using various analysis methods. This antibody also works in a two site ELISA with Clone 29/9.
| Institute |
|---|
| BioServ UK Ltd |
| Cat. #: | 153634 |
|---|---|
| Tool sub type: | Primary antibody |
| Unit size: | 100 ug |
| Research Fields: | Cancer;Cell signaling and signal transduction;Genetics;Immunology;Neurobiology |
| Application: | ELISA ; IHC ; WB |
| Target: | Follistation 288 |
| Reactivity: | Human |
| Clone: | 15 |
| Host: | Mouse |
| Class: | Monoclonal |
| Alternate name: | Follistatin, FS, FST, Active-binding protein |
|---|---|
| Product description: | Follistatin is a single-chain glycosylated protein that inhibits follicle stimulating hormone (FSH) release. Alternative splicing of Follistatin mRNA yields two isoforms, FS315 and FS288. FS288 is the main cell-surface form and binds to surface heparin sulphate proteoglycans. Clone 17/2 recognizes recombinant human Follistatin 288, allowing for detection of FSH levels using various analysis methods. This antibody also works in a two site ELISA with Clone 29/9. |
| Conjugation: | Unconjugated |
| Isotype: | IgG1 |
| Molecular weight: | 37 kDa |
| Immunogen: | Recognizes human Follistatin isoform FS288, raised against recombinant human FS288 |
| Myeloma used: | Sp2/0-Ag14 |
| Target background: | Follistatin is a single-chain glycosylated protein that inhibits follicle stimulating hormone (FSH) release. Alternative splicing of Follistatin mRNA yields two isoforms, FS315 and FS288. FS288 is the main cell-surface form and binds to surface heparin sulphate proteoglycans. Clone 17/2 recognizes recombinant human Follistatin 288, allowing for detection of FSH levels using various analysis methods. This antibody also works in a two site ELISA with Clone 29/9. |
|---|
| Format: | Liquid |
|---|---|
| Shipping conditions: | Dry ice |
| References: |
Hands et al. 2013. Anal Bioanal Chem. 405(23):7347-55. PMID: 23831829. Investigating the rapid diagnosis of gliomas from serum samples using infrared spectroscopy and cytokine and angiogenesis factors. Fitzgerald et al. 2012. Invest Ophthalmol Vis Sci. 53(11):7358-69. PMID: 23010638. The effects of transforming growth factor-?2 on the expression of follistatin and activin A in normal and glaucomatous human trabecular meshwork cells and tissues. Mabuchi et al. 2006. Oncol Rep. 15(2):291-6. PMID: 16391844. Immunohistochemical localization of inhibin and activin subunits, activin receptors, and Smads in ovarian clear cell adenocarcinoma. Pratic et al. 2004. Chem Phys Lipids. 128(1-2):165-71. PMID: 15037161. F2-isoprostanes as indices of lipid peroxidation in inflammatory diseases. Evans et al. 1998. J Endocrinol. 156(2):275-82. PMID: 9518873. Development, validation and application of an ultra-sensitive two-site enzyme immunoassay for human follistatin. Majdic et al. 1997. Endocrinology. 138(5):2136-47. PMID: 9112414. Testicular expression of inhibin and activin subunits and follistatin in the rat and human fetus and neonate and during postnatal development in the rat. |
|---|
| Cat. # | Tool Name | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 151016 | Anti-CyclinA [E72.1] |
Key Info
Anti-CyclinA [E72.1]
|
View Tool | |||||||||||||||||||
| 151019 | Anti-Mos [S3.1] |
Key Info
Anti-Mos [S3.1]
|
View Tool | |||||||||||||||||||
| 151027 | Anti-HSVICP8 [10A3] |
Key Info
Anti-HSVICP8 [10A3]
|
View Tool | |||||||||||||||||||
| 151037 | Anti-Cdk1 [17 (A17)] |
Key Info
Anti-Cdk1 [17 (A17)]
|
View Tool | |||||||||||||||||||
| 151020 | Anti-CyclinB1 [V143.1] |
Key Info
Anti-CyclinB1 [V143.1]
|
View Tool | |||||||||||||||||||
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.